Single gene mutation affects 60 million
19 January, 2009 by Kate McDonaldA deletion in a single gene increases risk of cardiomyopathies in South Asian populations
Robotnikinin takes on Sonic hedgehog
19 January, 2009 by Kate McDonaldSonic the hedgehog's nemesis strikes again, biologically speaking
Solving the case of the fainting astronaut
16 January, 2009 by Kate McDonaldA fascinating International Space Station-based research project about deconditioning of the autonomic nervous system could help future space travellers and other earthlings.
Alzheimer’s and the X factor
12 January, 2009 by Kate McDonaldStudy finds sex-specific risk SNP for late-onset Alzheimer’s
HDIs and oncology’s great hope
10 December, 2008 by Graeme O'NeillHistone deacetylase inhibitors (HDIs) have emerged as oncology’s Great Hope – rarely has a new class of drugs showed promise against such a broad range of cancers, including leukaemias, lymphomas and solid tumours.
Editing cancer with the immune system
09 December, 2008 by Fiona WylieMark Smyth is investigating a long-suspected but previously unproven role of the immune system – keeping cancer development in a holding pattern such that it neither grows nor gets ‘cured’.
Starpharma adds to STI inhibition
04 December, 2008 by Kate McDonaldMicrobicide inhibits HPV 16 and 18 in vivo
HIV proteins and cellular control
04 December, 2008 by Kate McDonaldThere are a multitude of potential targets that researchers throughout the world are studying in the fight against HIV, but this virus seems to have an answer for most of them.
Protein arrests cervical cancer growth
26 November, 2008 by Kate McDonaldBMP7 inhibits telomerase activity and cervical cancer cell growth
Polartechnics forecasts profit
25 November, 2008 by Kate McDonaldPolartechnics claims future profits in cervical cancer test
PEA and cancer cell self-cannibalisation
17 November, 2008 by Kate McDonaldUS researchers find protein induces autophagy in ovarian cancer
Sequencing the cancer genome
14 November, 2008 by Kate McDonaldPeter Campbell is part of a remarkably prolific group at the Wellcome Trust Sanger Institute that is using new technologies to sequence the cancer genome – or more correctly, genomes.
Acting on insulin
11 November, 2008 by Kate McDonaldGarvan researchers find novel action for insulin
City of Hope for HIV trial
22 October, 2008 by Kate McDonaldBenitec collaborator releases early results from RNAi trial for HIV
